Raptor Pharmaceutical Corp — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/db3afcef-4006-4c53-850c-ad725811dbf4/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-48.5M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-013558 |
| FY 2014 | $-40.0M | 2014-01-01 – 2014-12-31 | evidence 0001140361-15-009703 |
| FY 2013 | $-51.9M | 2013-01-01 – 2013-12-31 | evidence 0001070698-14-000018 |
| FY 2012 | $-126.5M | 2005-09-08 – 2013-03-31 | evidence 0001354488-13-002496 |
| FY 2011 | $-80.0M | 2005-09-08 – 2012-05-31 | evidence 0001070698-12-000058 |
| FY 2010 | $-13.1M | 2009-09-01 – 2010-08-31 | evidence 0001070698-12-000077 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Raptor Pharmaceutical Corp — all facts · Revenue · Net Income